Molecular diagnostics testing continues to see increased popularity with laboratories and has become an important component of respiratory virus surveillance and patient management. Multiplex panels with a high number of viral targets allow physicians to differentiate between common colds and more serious respiratory infections, such as H1N1. The availability of respiratory panels allows physicians to triage difficult cases and provide targeted treatment for patients when appropriate. The newest generation of molecular respiratory panels can provide same-day results, providing physicians with the relevant information they need in a clinically useful timeframe.
Jon Faiz Kayyem, PhD., Chief Scientific Officer, GenMark Diagnostics
